Pulmonary Embolism

FDA grants clearance for Triage D-Dimer Test

Published in Biotech Business Week, January 3rd, 2005

Biosite Incorporated (BSTE), a research-based provider of novel, rapid medical diagnostics, announced that the U.S. Food and Drug Administration granted the company clearance to market the Triage D-Dimer Test.

The diagnostic test is intended to be used as an aid in the assessment and evaluation of patients suspected of having thromboembolic events, including pulmonary embolism. Pulmonary embolism, or PE, is a blockage of one or more of the pulmonary arteries by blood clot, which is a common and highly lethal condition that is a leading cause of death in all age groups.

Portable and easy-to-use, this point-of-care diagnostic test can be used in the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2005-01-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry